Clinical Pharmacology of GP40321 (Insulin Glulisine Biosimilar): Pharmacokinetic and Pharmacodynamic Comparability in a Hyperinsulinemic‐Euglycemic Clamp Procedure

Documenti analoghi

• Bioequivalence Study of Velpatasvir/Sofosbuvir Oral Coated Tablets in Healthy Volunteers Under Fasting Conditions
  di: Sergei Noskov, et al.
  Pubblicazione: (2024)
• Population Pharmacokinetic and Pharmacodynamic Modeling of Romiplostim Biosimilar GP40141 and Reference Product in Healthy Volunteers to Evaluate Biosimilarity
  di: Igor Makarenko, et al.
  Pubblicazione: (2024)
• Immunogenicity, efficacy and safety of a biosimilar insulin glulisine compared with originator in adults with type 1 diabetes mellitus: A phase III randomised clinical trial
  di: Roman Drai, et al.
  Pubblicazione: (2025)
• Multicenter Single‐Blind Randomized Controlled Trial of the Romiplostim Biosimilar
  di: Anait L. Melikyan, et al.
  Pubblicazione: (2025)
• Comparing the Efficacy of Various Insulin Types: Pharmacokinetic and Pharmacodynamic Modeling of Glucose Clamp Effects in Healthy Volunteers
  di: Yi Chien Chang, et al.
  Pubblicazione: (2025)